Yin J, Li Y, Tian Y, Zhou F, Ma J, Xia S, et al
While some people report headaches as a side effect of tirzepatide, a growing body of research suggests that GLP-1 receptor agonists, the very class of drugs tirzepatide belongs to, might actually prevent migraines
After three months, reevaluating progress with a medical provider can help determine appropriate next steps, including whether adding a GLP-1 medication is warranted.
For weight management, only semaglutide (Wegovy) and liraglutide (Saxenda) are specifically licensed in the UK, with access typically through specialist weight management services according to NICE criteria
Effects of selenium on endothelial dysfunction and metabolic profile in low dose streptozotocin induced diabetic rats fed a high fat diet
Weight Regain Timeline and Metabolic Rebound Research published through 2025 indicates that patients who discontinue GLP-1 without lifestyle modification regain 2550% of lost weight within 12 months, with some regaining most or all weight within 1824 months
